CARB-X funds Eligo Bioscience to develop CRISPR-based therapeutics derived from bacteriophages to kill superbugs and prevent deadly infections in transplant patients

Gene editing

Home » Emerging technologies » Gene editing

Synthego Adopts Good Manufacturing Practices for Highest-Quality Genome Engineering for Clinical Applications

LogicBio Therapeutics Announces Collaboration with Takeda to Develop New Genome Editing Candidate LB-301 for the Treatment of Crigler-Najjar Syndrome

Locus Biosciences initiates world’s first controlled clinical trial for a CRISPR enhanced bacteriophage therapy

SNIPR BIOME Strengthens Lead in CRISPR-based Medicines to Treat Microbiomes

CRISPR Prime

With CRISPR Prime, gene therapies are one step closer to curing millions

Mammoth Biosciences Strengthens Executive Management With Biotech Veterans, Peter Nell and Ted Tisch

GenEdit and Editas Medicine Enter into Exclusive License and Collaboration Agreement for Nanoparticle Gene Therapy Delivery

Inscripta Raises $125M in Series D Financing to Accelerate Commercialization of Revolutionary Digital Genome Engineering Platform

Cyrus Biotechnology and the Broad Institute of MIT and Harvard Launch Multi-Target Collaboration to Develop Optimized CRISPR Gene Editing Technology

Caribou Biosciences Announces New Methods to Harness Type I CRISPR-Cas Systems for Genome Engineering in Human Cells